Song Ruilin, President of China Pharmaceutical Promotion Association: Determine the price of innovative drugs based on clinical value and determine the payment ratio according to the ability to pay

China Net Finance, September 6 (Reporter Duan Siqi) September 2-7, 2021 China International Trade in Services Fair (hereinafter referred to as "Service Trade Fair") will be held in Beijing.

.
It is divided into six themes of epidemic prevention and control, medical services, technological innovation, traditional medicine, elderly health, and international medical care

Song Ruilin, Executive Chairman of China Pharmaceutical Innovation Promotion Association, was interviewed by reporters.

Song Ruilin, executive chairman of the China Pharmaceutical Innovation Promotion Association, said in an interview with a reporter from Chinanet.
com that the establishment of the health and hygiene section of the Service and Trade Association reflects the country's great attention to the field of people's health
.
We strive to show the entire chain of health, medical, and pharmaceutical innovation.

Song Ruilin introduced that in this special exhibition, we will display medical treatment and medicine together.
Medical treatment is the main battlefield facing patients, so medicine and equipment are the weapons in the hands of doctors when they are engaged in medical services
.
This is also the chain of translational medicine.

The medical insurance negotiations in 2021 are approaching, what room for improvement in the rules of the current innovative drug negotiations? What are the obstacles and difficulties in the commercial insurance reimbursement system for innovative drugs?

Song Ruilin told a reporter from Chinanet.
com that we must think about a problem, that is, generic drugs and innovative drugs are two completely different products
.
After the patent period of innovative drugs expires, a large number of generic drugs will appear

"Our drug review and approval system has been in line with international standards.
Medical insurance plays a huge role in market regulation.
The payment policy reflects the value of innovative drugs.
Therefore, I think it is necessary to establish a separate payment guarantee system for innovative drugs
.
" Song Ruilin suggested "It is not to let medical insurance be fully supported, but the price must be determined by clinical value and its comprehensive social value.

"Innovative drugs should not only look at its price, but also have an experience of its comprehensive social value